Mallinckrodt plc, a global specialty pharmaceutical company, today announced that it will report its fourth quarter and fiscal year 2024 financial results on Tuesday, March 11, 2025.
Mallinckrodt's liability problems in the US have been lightened slightly, after it agreed a $260 million deal to resolve allegations of Medicare rebate fraud and payment of illegal kickbacks.
Mallinckrodt looks like it could join Purdue Pharma in reaching a settlement in its bankruptcy proceedings related to opioid litigation, after years of legal wrangling. The Ireland-headquartered ...
Researchers at Washington University in St. Louis Medicine Mallinckrodt Institute of Radiology have identified specific neuronal cells that are essential to our understanding of other people. Runnan ...
Hosted on MSN11mon
Senate passes stand-alone bill to extend, expand compensation for radiation victimsJosh Hawley’s (R-Mo.) constituents in the St. Louis area who were exposed to contaminated water from uranium production at Mallinckrodt Chemical Works. An amendment expanding and extending RECA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results